Physician

Gurvinder S Shaheed, M.D.

According to 2025 Medicare claims, Gurvinder Shaheed, M.D. (NPI: 1548213705) practices hematology/oncology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Placer, CA. This provider's primary affiliated billing organization is DIGNITY HEALTH MEDICAL FOUNDATION (NPI: 1700803418; TIN: 770359115) and primary practice location at 95765-5396. Shaheed is affiliated with the CommonSpirit ACO I (ACO ID: A2164), participating under the MSSP model.

Shaheed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 429 traditional Medicare patients, billed 71,864 HCPCS/CPT codes, and received $1,387,504 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 831 prescription claims across 164 beneficiaries totaling $1,613,797 in drug costs, led by Imbruvica (Ibrutinib). 2019 DME data shows 47 claims. Open Payments data shows 2 records totaling $32. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $489,011 to $1,387,504. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	386	31,556	$489,011
2016	380	34,886	$671,823
2017	407	46,052	$871,981
2018	401	46,329	$897,998
2019	402	39,246	$989,612
2020	383	42,016	$860,440
2021	388	39,327	$943,558
2022	400	52,625	$1,107,145
2023	431	45,537	$1,235,361
2024	429	71,864	$1,387,504

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	142	1,005	$1,192,493
2016	174	1,241	$1,393,303
2017	161	961	$1,378,709
2018	177	1,021	$1,931,944
2019	168	1,088	$2,732,438
2020	146	1,077	$2,436,521
2021	147	958	$2,165,180
2022	142	917	$2,145,173
2023	164	919	$2,678,271
2024	164	831	$1,613,797

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	104	$61,465
2016	N/R	14	$263
2017	N/R	50	$13,978
2018	N/R	59	$11,034
2019	N/R	47	$6,190
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	66	200	$155
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	378	$104
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	94	219	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	185	397	$13
J3489	Injection, zoledronic acid, 1 mg	69	366	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	32	896	$515,754
Bosulif	Bosutinib	12	360	$112,131
Abiraterone Acetate	Abiraterone Acetate	15	450	$28,797
Xarelto	Rivaroxaban	17	810	$14,735
Eliquis	Apixaban	19	720	$13,951

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$32	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gurvinder S. Shaheed, M.D.?

Tedicare shows public-source Medicare data for Gurvinder S. Shaheed, M.D. (NPI 1548213705), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gurvinder S. Shaheed, M.D. have ACO affiliation data?

Gurvinder S. Shaheed, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164).

What billing organization is linked to Gurvinder S. Shaheed, M.D.?

Gurvinder S. Shaheed, M.D. is linked to DIGNITY HEALTH MEDICAL FOUNDATION (billing NPI 1700803418) in the available physician profile data.

Does Gurvinder S. Shaheed, M.D. have Open Payments data?

Gurvinder S. Shaheed, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.